NJ State Employees Deferred Compensation Plan’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-22,000	Closed	-$15K	–	520
2020 Q4	$15K	Hold	22,000	–	–	﹤0.01%	504
2020 Q3	$50K	Hold	22,000	–	–	0.01%	482
2020 Q2	$79K	Hold	22,000	–	–	0.01%	476
2020 Q1	$84K	Hold	22,000	–	–	0.02%	446
2019 Q4	$66K	Buy	+22,000	New	+$57.2K	0.01%	525

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's BMY.RT Position: Q1 2021 in Review

NJ State Employees Deferred Compensation Plan sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 22,000 shares — an estimated $15K sold.

NJ State Employees Deferred Compensation Plan first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $84K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

NJ State Employees Deferred Compensation Plan reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
NJ State Employees Deferred Compensation Plan sold 22,000 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $15K.
NJ State Employees Deferred Compensation Plan first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
NJ State Employees Deferred Compensation Plan's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $84K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2021, filed 26 Apr 2021.